Helicobacter pylori public health implications

Helicobacter
Paul Moayyedi, Richard Hunt

Abstract

Population Helicobacter pylori screening and treatment has the potential to dramatically reduce global gastric cancer mortality. There is overwhelming evidence that the infection is a major cause of distal gastric adenocarcinoma. There is also randomized controlled trial evidence that H. pylori eradication reverses or ameliorates histological changes in the gastric mucosa that are important in carcinogenesis. Preliminary randomized controlled trial data suggest that screening and treatment may reduce the risk of gastric cancer although the number of cancer cases was small. Population H. pylori screening and treatment will also reduce mortality from peptic ulcer complications and reduce the burden of dyspepsia in the community. The reduction in health service dyspepsia costs means that this could be the first programme to pay for itself. From a scientific perspective, we still have insufficient evidence to conclude the benefits of population H. pylori screening are greater than the possible harms and we need more randomized controlled trial data. From a public health perspective however, sometimes screening programmes are developed with imperfect information. The medical community should be consistent and if we are instituting o...Continue Reading

References

Aug 1, 1992·BMJ : British Medical Journal·P J Edwards, D M Hall
Mar 1, 1996·Gut·T A RockallT C Northfield
Feb 16, 2000·Lancet·P C Gøtzsche, O Olsen
May 5, 2000·The Cochrane Database of Systematic Reviews·B C DelaneyD Forman
Mar 27, 2001·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·H Inoue, H K Seitz
Oct 31, 2001·Lancet·R Horton
Nov 1, 2001·The Cochrane Database of Systematic Reviews·B C DelaneyD Forman
Dec 18, 2001·Journal of Medical Screening·G Meystre-AgustoniF Dubois-Arber
Jan 8, 2003·International Journal of Cancer. Journal International Du Cancer·Anna H WuDavid Forman
Jan 31, 2003·Gastroenterology·Sidney WinawerUNKNOWN Gastrointestinal Consortium Panel
Apr 5, 2003·BMJ : British Medical Journal·Anan RaghunathSusan Childs
Jun 14, 2003·The Cochrane Database of Systematic Reviews·B C DelaneyD Forman
Jul 8, 2003·Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie·Anthony Axon
Jul 16, 2003·Archives of Internal Medicine·Nicolaas L A ArentsJan H Kleibeuker
Aug 2, 2003·Gastroenterology·Mette Wildner-ChristensenOve B Schaffalitzky De Muckadell
Sep 19, 2003·Annals of Internal Medicine·Maria SjölundLars Engstrand
Jan 15, 2004·JAMA : the Journal of the American Medical Association·Benjamin Chun-Yu WongUNKNOWN China Gastric Cancer Study Group
Jan 15, 2004·JAMA : the Journal of the American Medical Association·Julie Parsonnet, David Forman
Jan 16, 2004·Gastroenterology·Jia Qing HuangRichard H Hunt
Jan 17, 2004·Alimentary Pharmacology & Therapeutics·D Forman, D Y Graham
Jan 28, 2004·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Catherine LeyJulie Parsonnet
Apr 20, 2004·The American Journal of Medicine·George V PapatheodoridisStephanos J Hadziyannis
May 21, 2004·Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie·Terrence SullivanNicola Jones
Jun 12, 2004·BMJ : British Medical Journal·Brendan Delaney, Paul Moayyedi
Aug 28, 2004·The American Journal of Gastroenterology·Alexander C FordPaul Moayyedi

❮ Previous
Next ❯

Citations

Oct 4, 2006·Journal of Clinical Gastroenterology·Mariela QuesadaFerran Segura
Jan 26, 2006·The American Journal of Surgical Pathology·Veronika ZsiklaGieri Cathomas
Jul 11, 2012·Gastroenterology Research and Practice·Sotirios D GeorgopoulosStylianos Karatapanis
Sep 9, 2008·World Journal of Gastroenterology : WJG·Zhi-Qiang LiuPing-Chang Yang
Jul 2, 2009·Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association·Abdulwahab M A Telmesani
Feb 25, 2006·Digestion·Xavier Calvet
Sep 4, 2015·Expert Opinion on Pharmacotherapy·Sotirios D GeorgopoulosStylianos Karatapanis
Mar 27, 2007·Best Practice & Research. Clinical Gastroenterology·Paul Moayyedi
Jun 14, 2005·Alimentary Pharmacology & Therapeutics·C A M McNultyB C Delaney
Jan 22, 2013·Expert Opinion on Pharmacotherapy·Sotirios D GeorgopoulosStylianos Karatapanis
Aug 10, 2005·The American Journal of Gastroenterology·X CalvetUNKNOWN Hp Study Group of the Asociación Española de Gastroenterología
Aug 12, 2014·World Journal of Gastroenterology : WJG·Vasilios PapastergiouStylianos Karatapanis
Oct 28, 2017·Applied Microbiology and Biotechnology·Kamila GoderskaTeresa Alarcon
Jan 27, 2016·World Journal of Gastroenterology : WJG·Vasilios PapastergiouSotirios D Georgopoulos
Dec 5, 2019·Arquivos De Gastroenterologia·Michele Fernandes RodriguesSônia Maria Neumann Cupolilo
Jan 6, 2019·Applied Microbiology and Biotechnology·Nuzhat QureshiQing Gu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.